ID
25714
Description
Study ID: 101468/197 Clinical Study ID: SKF-101468/197 Study Title:An open study to compare the PK and tolerability of ropinirole administered as 5 different new formulations with the standard, marketed formulation in healthy volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication : Restless Legs Syndrome
Keywords
Versions (1)
- 9/12/17 9/12/17 -
Copyright Holder
GlaxoSmithKline
Uploaded on
September 12, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
final examination physical examination PK and tolerability of ropinirole as 5 new formulations 101468/197
final examination physical examination PK and tolerability of ropinirole as 5 new formulations 101468/197
Description
Physical Examination
Alias
- UMLS CUI-1
- C0031809
Description
If Yes, Record below. Any clinically relevant worsening since the last examination must be recorded on the Adverse Event page.
Data type
text
Alias
- UMLS CUI [1,1]
- C0031809
- UMLS CUI [1,2]
- C0443172
Description
changes from last physical examination
Data type
text
Alias
- UMLS CUI [1,1]
- C0031809
- UMLS CUI [1,2]
- C0443172
Similar models
final examination physical examination PK and tolerability of ropinirole as 5 new formulations 101468/197
C0443172 (UMLS CUI [1,2])
C0443172 (UMLS CUI [1,2])